Vertex Pharmaceuticals (VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ ...
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
The Associated Press on MSN10d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioidsU.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback